Preparation and characterization of micronized artemisinin via a rapid expansion of supercritical solutions (RESS) method

International Journal of Molecular Sciences

Volumn 13, Issue 4, 2012, Pages 5060-5073

  Yu, Huimin ^a   Zhao, Xiuhua ^b   Zu, Yuangang ^b   Zhang, Xinjuan ^b   Zu, Baishi ^b   Zhang, Xiaonan ^b  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b NORTHEAST FORESTRY UNIVERSITY   (China)

Author keywords

Artemisinin; Micronization; RESS; Supercritical fluids

Indexed keywords

ARTEMISININ; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; DRUG;

ARTICLE; BULK DENSITY; CHEMICAL PROCEDURES; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; DRUG STRUCTURE; EXTRACTION; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MELTING POINT; MICRONIZATION; PARTICLE SIZE; POWDER; PRECIPITATION; PRESSURE; PROCESS OPTIMIZATION; RAPID EXPANSION OF SUPERCRITICAL SOLUTIONS; SCANNING ELECTRON MICROSCOPY; TEMPERATURE; X RAY DIFFRACTION; BIOAVAILABILITY; CHEMISTRY; DRUG DELIVERY SYSTEM;

ANTIMALARIALS; ARTEMISININS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, LIQUID; DRUG DELIVERY SYSTEMS; MASS SPECTROMETRY; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; X-RAY DIFFRACTION;

EID: 84860199167     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13045060     Document Type: Article

References (28)

1. Klayman, D.L. Qinghaosu (artemisinin): An antimalarial drug from China. Science 1985, 228, 1049-1055.
2. Dong, J.X.; Dan, Y.M.; Tan, Z.C.; Zhao, J.N.; Liu, Y. Low temperature molar heat capacities and thermal stability of crystalline artemisinin. Thermochim. Acta 2007, 463, 2-5.
3. O'Neill, P.M.; Posner, G.H. A medicinal chemistry perspective on artemisinin and related endoperoxides. J. Med. Chem. 2004, 47, 2945-2964.
4. Haynes, R.K.; Fugmann, B.; Stetter, J.; Rieckmann, K.; Heilmann, H.D.; Chan, H.W.; Cheung, M.K.; Lam, W.L.; Wong, H.N.; Croft, S.L., et al. Artemisone-A highly active antimalarial drug of the artemisinin class. Angew. Chem. Int. Ed. Engl. 2006, 45, 2082-2088.
5. World Health Organization (WHO). Assessment of the Safety of Artemisinin Compounds in Pregnancy; WHO: Geneva, Switzerland, 2003; Volume 14.
6. Dhingra, V.; Rao, K.V.; Narasu, M.L. Current status of artemisinin and its derivatives as antimalarial drugs. Life Sci. 2000, 66, 279-300.
7. Meshnick, S.R. Artemisin: Mechanisms of action, resistance and toxicity. Int. J. Parasitol. 2002, 32, 1655-1660.
8. Hien, T.T.; White, N.J. Qinghaosu. Lancet 1993, 341, 603-608.
9. Wiesner, J.; Ortmann, R.; Jomaa, H.; Schlitzer, M. New antimalarial drugs. Angew. Chem. Int. Ed. Engl. 2003, 42, 5274-5293.
10. Luo, X.D.; Shen, C.C. The chemistry, pharmacology and clinical application of qinghaosu (artemisinin) and its derivatives. Med. Res. Rev. 1987, 7, 29-52.
11. Perrut, M.; Jung, J.; Leboeuf, F. Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes: Part I: Micronization of neat particles. Int. J. Pharm. 2005, 288, 3-10.
12. Kim, M.S.; Lee, S.; Park, J.S.; Woo, J.S.; Hwang, S.J. Micronization of cilostazol using supercritical antisolvent (SAS) process: Effect of process parameters. Powder Technol. 2007, 177, 64-70.
13. Pasquali, I.; Bettini, R.; Giordano, F. Solid-state chemistry and particle engineering with supercritical fluids in pharmaceutics. Eur. J. Pharm. Sci. 2006, 27. 299-310.
14. Berg, H.; Turner, C.; Dahlberg, L.; Mathiasson, L. Determination of food constituents based on SFE: Applications to vitamins A and E in meatand milk. J. Biochem. Biophys. Methods 2000, 43, 391-401.
15. Jarzebski, A.B.; Janusz, J.M. Potentials and prospects for application of supercritical fluid technology in bioprocessing. Process Biochem. 1995, 30, 343-352.
16. Hauthal, W.H. Advances with supercritical fluids. Chemosphere 2001, 43, 123-135.
17. Mandel, F.S.; Wang, J.D. Manufacturing of specialty materials in supercritical fluid carbon dioxide. Inorg. Chim. Acta 1999, 294, 214-223.
18. Turk, M. Formation of small organic particles by RESS: Experimental and theoretical investigations. J. Supercrit. Fluids 1999, 15, 79-89.
19. Tom, J.W.; Debenedetti, P.G. Formation of bioerodable polymeric microspheres and microparticles by rapid expansion of supercritical solutions. Biotechnol. Prog. 1991, 7, 403-411.
20. Hirunsit, P.; Huang, Z.; Srinophakun, T.; Charoenchaitrakool, A.; Kawi, S. Particle formation of ibuprofen-supercritical CO2 system from rapid expansion of supercritical solutions (RESS): A mathematical model. Powder Technol. 2005, 154, 83-94.
21. Dennis, B.; Michael, T. Micronisation of carbamazepine through rapid expansion of supercritical solution (RESS). J. Supercrit. Fluids 2012, 62, 32-40.
22. Ali, K.; Javad, K.S.; Alborz, F.; Aboo, A.G.; Morteza, R.T.; Farid, A.D. Preparation and characterization of raloxifene nanoparticles using rapid expansion of supercritical solution (RESS). J. Supercrit. Fluids 2012, 63, 169-179.
23. Helfgen, B.; Turk, M.; Schaber, K. Hydrodynamic and aerosol modelling of the rapid expansion of supercritical solutions (RESS-process). J. Supercrit. Fluids 2003, 26, 225-242.
24. Weber, M.; Thies, M.C. A simplified and generalized model for the rapid expansion of supercritical solutions. J. Supercrit. Fluids 2007, 40, 402-419.
25. Defne, K.; Ugur, A.; Oner, H. Micronization of ibuprofen by RESS. J. Supercrit. Fluids 2003, 26, 17-31.
26. Xing, H.B.; Yang, Y.W.; Su, B.G.; Huang, M.; Ren, Q.L. Solubility of artemisinin in supercritical carbon dioxide. J. Chem. Eng. Data 2003, 48, 330-332.
27. Viktor, M.; Gérard, C.; Elisabeth, B.; Geza, H.; Lazlo, S.; Nathalie, B.; Eric, T. Bioavailability enhancement of an active substance by supercritical antisolvent precipitation. J. Supercrit. Fluids 2007, 40, 101-110.
28. United States Pharmacopoeia; United States Pharmacopeial Convention Inc.: Rockville, MD, USA, 2005; Volume 28, p. 2374.